Jeremy Schieler is a Senior Manager in Technology Licensing and Collaborations at AbbVie Inc. where he is responsible for managing and negotiating IP-related transactions across AbbVie's R&D pipeline. Prior to AbbVie Jeremy worked at The Coca-Cola Company as an IP Strategist in Ingredient Research where he negotiated external research and development agreements and developed IP strategy for The Coca-Cola Company Ingredient Research team. Prior to this, Jeremy spent nearly 10 years in technology commercialization at Community Health Network (Director, Commercialization) and Indiana University Research and Technology Corporation where he most recently served as Director of Technology Commercialization.
Jeremy received his Ph.D. in Medicinal Chemistry and Molecular Pharmacology and B.S. in Pharmaceutical Sciences from Purdue University, was a Postdoctoral Fellow in Neurology at Brigham and Women's Hospital and Harvard Medical School and is a Registered Patent Agent with the United States Patent and Trademark Office.